WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
21 Bridge Street
Metuchen, NJ 08840, USA
Tel/Fax: +1 801-751-5728
info@pharmachinaonline.com

Affiliated Companies
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

BJ Jicai PharmTech
Oriental Kenzo Plaza
Beijing, China
Tel: +86 10 84476010
info@pharmachinaonline.com

China Tightens Grip on Pharma Industry as It Initiates the 5th Round of VBP Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with emphasis on latest market data, recent government actions on monopoly, BMI financi...
(5/4/2021)

China Tightens Grip on Pharma Industry as It I... (5/4/2021)

Simcere Pharma Ditches Cell Therapy to Focus o... (4/27/2021)

BioPlan: Chinese CDMO Sector Growing but Unlik... (4/27/2021)

Collaborating for Success: Pfizer's China Head... (4/23/2021)

The Rise of Digital Healthcare Services amid C... (4/22/2021)

NHC Looks into Allegation Cancer Doctor Gave P... (4/20/2021)

Politico: Made-in-China Pills Come with Unwant... (4/20/2021)

PhIRDA/RDPAC: Fostering China Pharmaceutical I... (4/19/2021)

How China Passed Up a Vaccine Opportunity and ... (4/15/2021)

FiercePharma: BeiGene Details Novartis-partner... (4/12/2021)

PharmaDJ's China Biotech Fundraising Tracker: ... (4/12/2021)

MNCs Rethink China Strategy as New Opportuniti... (4/8/2021)

GlobalData: New Chinese Priority Review ... (5/4/2021) Recent Official and Executive Moves (4/30/2021) Financial-related Company News in Brief (4/30/2021) CDE Solicits Comments on the Technical G... (4/30/2021) CDE Solicits Comments on the Technical G... (4/30/2021) Sirnaomics Enters Partnership with Walva... (4/30/2021) CROs dMed and Clinipace Merge to Acceler... (4/30/2021) (Free) PhIIC: Performance Review of Drug Produc... (4/29/2021) Top 20 Listed Chinese Pharmaceutical Com... (4/29/2021) Tianyao Fined CNY 44M for Antimonopoly V... (4/29/2021) Sanofi Reports China Sales Growth amid D... (4/29/2021) LG Chem Signs Strategic Partnership Cont... (4/29/2021) Shanghai Launches Customized BMI Supplem... (4/28/2021) Vaccine Startup Clover Biopharma Files f... (4/27/2021) (Free) CANbridge Licenses LogicBio's Gene Deliv... (4/27/2021) Upcoming Event: 2nd International Women ... (4/27/2021) (Free) Upcoming Event: 6th Cell & Gene Therapy ... (4/27/2021) (Free) Annual Report of the Intellectual Proper... (4/27/2021)

PhIIC: Performance Review of Drug Products Included in ... SMEI: Review of Chinese Terminal Drug Markets in 2011 -... GlobalData: Cheap Chinese ICIs May Shake Global Oncolog... NH's DB6: Chinese OTC Drug Market Forecast 2025/2030 (U... Top Ten Chemical Drugs and Brands in Major Chinese Urba...

CROs dMed and Clinipace Merge to Accelerate Customer Su... Sirnaomics Enters Partnership with Walvax to Co-Develop... Financial-related Company News in Brief LG Chem Signs Strategic Partnership Contract with China... Sanofi Reports China Sales Growth amid Dupixent's Launc...

GlobalData: New Chinese Priority Review Designation Fai... CDE Solicits Comments on the Technical Guidelines for P... CDE Solicits Comments on the Technical Guidelines for C... NMPA Issues the List of Reference Formulations for GQCE... China and Mexico Sign Regulatory Cooperation Agreement ...

Shanghai Launches Customized BMI Supplemental Health In... China Issues the 2021 Highlights of Correction of Irreg... State Council Introduces New Policy to Establish/Enhanc... NHC Approves Setup of National Medical Centers for Infe... Latest Update on the Upcoming 5th Round of VBP

Tianyao Fined CNY 44M for Antimonopoly Violations Annual Report of the Intellectual Property Tribunal of ... US Jails Medical Researcher for Conspiring to Sell Trad... Numerous Local Champions and MNCs Among the 19 Pharma C... Chinese MOF Fines 19 Pharma Companies for Inflating Dru...

Teva CEO Talks About Risks in Excessive Reliance on Chi... Indian Pharma Firms Go Local Seeking to End Reliance on... India Probes Alleged API Dumping by Chinese Companies China Increases Prices of Key Drug Ingredients by Up To... U.S. Introduces A 'Buy American First' Pharma Executive...

CStone's NDA of Selective Inhibitor GAVRETO(R) (Pralset... I-Mab Announces Positive Topline Phase 2 Results for Ol... SciClone Pharma Tests Hepatitis Drug as COVID-19 Vaccin... Hua Medicine Files Chinese NDA for Dorzagliatin China Experiments Mixing Two Homegrown Covid Vaccines...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

Upcoming Event: 6th Cell & Gene Therapy Summit 2021 Upcoming Event: 2nd International Women Health and Brea... Upcoming Event: 5th Annual Markets and Markets Bioproce... U.S. Chamber Releases In-Depth Analysis of U.S.-China E... Upcoming Event: Plenareno Pharma Middle East Virtual Co...

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

Pharma China on Twitter and Faceboo... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON to Hold Pharma China Annual F... WiCON Publishes the China Pharmaceu...